Putative TAAR5 agonist alpha-NETA affects event-related potentials in oddball paradigm in awake mice.

Brain Research Bulletin
Aleksander A AleksandrovNadezhda V Polyakova

Abstract

Trace amines have been reported to be neuromodulators of monoaminergic systems. Trace amines receptor 5 (TAAR5) is expressed in several regions of mice central nervous system, such as amygdala, arcuate nucleus and ventromedial hypothalamus, but very limited information is available on its functional role. The purpose of this study is to examine the effect of TAAR5 agonist alpha-NETA on the generation of mismatch negativity (MMN) analogue in C57BL/6 mice. Event-related potentials have been recorded from awake mice in oddball paradigms before and after the alpha-NETA administration. Alpha-NETA has been found to decrease N40 MMN-like difference, which resulted from the increased response to standard stimuli. An opposite effect has been found for the P80 component: the amplitude increased in response both to standard and deviant stimuli. A significant increase in N40 peak latency after the alpha-NETA administration has been found. This may suggest a reduced speed of information processing similar to the increase in P50 and N100 components latencies in schizophrenia patients. These results provide new evidence for a role of TAAR5 in cognitive processes.

References

Jul 1, 1978·Acta Psychologica·R NäätänenS Mäntysalo
Oct 1, 1992·Journal of Psychiatric Research·P S Holzman
Jan 1, 1973·The British Journal of Psychiatry : the Journal of Mental Science·I I Gottesman, J Shields
Aug 1, 1980·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A A Boulton
Jan 1, 1995·The International Journal of Neuroscience·R Näätänen, K Alho
Sep 1, 1994·Journal of Neurophysiology·N KrausC King
Sep 1, 1993·Psychophysiology·R NäätänenK Alho
May 17, 1996·Neuroreport·T RuusuvirtaK Kivirikko
Jul 17, 1998·Neuroscience Letters·T RuusuvirtaT Korhonen
Jul 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·B BorowskyC Gerald
Sep 15, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S KähkönenE Pekkonen
Oct 6, 2001·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·P T Michie
Dec 5, 2002·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Seppo KähkönenIiro P Jääskeläinen
Jan 29, 2003·Current Opinion in Pharmacology·Theresa A Branchek, Thomas P Blackburn
Apr 2, 2003·The American Journal of Psychiatry·Irving I Gottesman, Todd D Gould
Jan 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christina R MaxwellSteven J Siegel
Jan 22, 2005·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·D UmbrichtH-P Lipp
Feb 9, 2005·Archives of General Psychiatry·Gregory A Light, David L Braff
Feb 22, 2005·Psychophysiology·Risto NäätänenIstván Winkler
Apr 30, 2005·Trends in Pharmacological Sciences·Lothar Lindemann, Marius C Hoener
Jun 2, 2005·Schizophrenia Research·Daniel Umbricht, Sanya Krljes
Jul 15, 2005·Psychiatry Research·Sandrine Louchart-de la ChapelleFlorence Thibaut
May 16, 2006·Trends in Genetics : TIG·Carrie E Bearden, Nelson B Freimer
Nov 8, 2006·British Journal of Pharmacology·R ZucchiD K Grandy
Dec 18, 2007·The Journal of Pharmacology and Experimental Therapeutics·Lothar LindemannMarius C Hoener
Feb 29, 2008·Journal of Cognitive Neuroscience·Richard S EhrlichmanSteven J Siegel
Sep 6, 2008·The International Journal of Neuropsychopharmacology·Risto Näätänen, Seppo Kähkönen
Apr 25, 2009·Molecular Pharmacology·Tatyana D SotnikovaRaul R Gainetdinov
Apr 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Florent G RevelMarius C Hoener
Oct 18, 2011·Behavioural Processes·Tiffani J HowellPauleen Bennett
Nov 2, 2014·Frontiers in Physiology·Riccardo ZucchiGrazia Chiellini
Jan 24, 2015·Current Opinion in Neurobiology·Stephen D Liberles
Mar 10, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stefano EspinozaRaul R Gainetdinov
Mar 11, 2015·Annals of the New York Academy of Sciences·Gregory A Light, Neal R Swerdlow

❮ Previous
Next ❯

Citations

Aug 28, 2021·International Journal of Molecular Sciences·Anastasia N VaganovaRaul R Gainetdinov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.